國中水務(600187.SH)擬共同設立康養產業公司 持股佔比20%
格隆匯3月30日丨國中水務(600187.SH)公佈,公司擬與上海鵬都健康科技發展有限公司(以下簡稱“鵬都健康”)簽署《投資協議》,共同出資設立上海鵬都頤養健康科技發展有限公司(以工商最終核名為準,以下簡稱“合資公司”,註冊地為中國上海市崇明城橋經濟開發區),致力構建以健康管理為核心的綜合性服務平台。合資公司註冊資本為10億元人民幣,其中鵬都健康以現金方式出資8億元人民幣,持股比例為80%;公司以現金方式出資2億元,持股比例為20%。本次對外投資是公司佈局康養產業、實現業務拓展的有益嘗試,旨在進一步提升公司整體盈利能力,有利於公司的長遠發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.